Puma Biotechnology PBYI
NASDAQ PBYI
$9.51 -0.33 (-3.35%)
At close: Oct 2, 2026 · 4:00 PM EDT

Puma Biotechnology (PBYI) Selling, General & Administrative (2010 - 2026)

Updated

Puma Biotechnology (PBYI) recorded Selling, General & Administrative of $17.55 million in Q2 2026, down 2.8% from $18.05 million a year earlier and down 4.8% from the prior quarter.

Analysis

Puma Biotechnology (PBYI) Selling, General & Administrative (2010 - 2026) Analysis & Trends

On a TTM basis, Puma Biotechnology's Selling, General & Administrative came in at $71.17 million as of Jun 30, 2026, up 3.0% year-over-year; for FY2025, it was $70.85 million, down 11.6% from FY2024.

  • Annual Selling, General & Administrative has declined for seven straight years, with a five-year compound annual growth rate of -9.8% (FY2020 to FY2025).
  • Across earlier years, Selling, General & Administrative came in at $80.16 million in FY2024 (-10.9%), $89.93 million in FY2023 (-0.1%), $89.98 million in FY2022 (-22.6%) and $116.29 million in FY2021 (-1.9%).
  • Quarterly Selling, General & Administrative has ranged from $16.62 million in Q4 2024 to $26.08 million in Q3 2021 over the past five years.
  • On a year-over-year basis, Selling, General & Administrative rose in two of the last eight quarters, with an average decline of 9.8%.
  • Peak year-over-year performance for Selling, General & Administrative in the last five years was growth of 18.9% in Q2 2023, against a decline of 47.8% in Q2 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $18.42 million (Q1 2026), $18.38 million (Q4 2025) and $16.82 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Puma Biotechnology 485.99 Mn 98.62 Mn 44.03 Mn 17.55 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 17.55 Mn
Mar 31, 2026 18.42 Mn
Dec 31, 2025 18.38 Mn
Sep 30, 2025 16.82 Mn
Jun 30, 2025 18.05 Mn
Mar 31, 2025 17.60 Mn
Dec 31, 2024 16.62 Mn
Sep 30, 2024 16.82 Mn
Jun 30, 2024 24.97 Mn
Mar 31, 2024 21.75 Mn
Dec 31, 2023 20.18 Mn
Sep 30, 2023 22.80 Mn
Jun 30, 2023 24.46 Mn
Mar 31, 2023 22.49 Mn
Dec 31, 2022 25.04 Mn
Sep 30, 2022 23.96 Mn
Jun 30, 2022 20.58 Mn
Mar 31, 2022 20.40 Mn
Dec 31, 2021 22.46 Mn
Sep 30, 2021 26.08 Mn
API Access

Puma Biotechnology Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=PBYI&period=max&api_key=YOUR_API_KEY